The CUPID (Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease) trial was the first gene therapy clinical study targeting SERCA2a in HF
A medical weight loss treatment plan provided and supervised by Dr
How GLP-1 Medications Became a Regulatory Focus The rapid commercial expansion caught the attention of regulators
Getting GLP-1 without insurance is quick, safe, and affordable with LifeRx.md
Dunlop has received research support from Boehringer Ingelheim, Compass Pathways, NIMH, Otsuka, Sage, Usona Institute, and Takeda and has served as a consultant for Biohaven, Cerebral Therapeutics, Myriad Neuroscience, NRx Pharmaceuticals, Otsuka, and Sage
Evidence for its efficacy in people who are not biotin-deficient is limited